SCHEMBL195530

SCHEMBL195530

Oc1ccccc1-c1nc(-c2ccccc2O)nc(-c2ccccc2O)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.71
MAPK1 P28482 4/20 0.69
TSHR P16473 5/20 0.64
ADORA2A P29274 2/20 0.64
ALOX15 P16050 2/20 0.64
ADORA3 P0DMS8 1/20 0.64
ADORA2B P29275 1/20 0.64
ADORA1 P30542 1/20 0.64
CASP3 P42574 2/20 0.59
SENP8 Q96LD8 2/20 0.59
SENP7 Q9BQF6 2/20 0.59
SENP6 Q9GZR1 2/20 0.59
ALDH1A1 P00352 5/20 0.59
KMT2A Q03164 4/20 0.57
HSD17B10 Q99714 6/20 0.55
HPGD P15428 5/20 0.52
BCL2L1 Q07817 1/20 0.52
KDM4A O75164 1/20 0.50
MAPT P10636 6/20 0.49
KDM4E B2RXH2 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29502789 1.00 SMN1; SMN2 (0.71) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL8490844 0.89 SMN1; SMN2 (0.92) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL14112069 0.89 ALDH1A1 (0.76) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL29481861 0.89 TSHR (0.82) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL7577322 0.89 TSHR (0.82) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL296255 0.89 TSHR (0.82) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL9444970 0.87 SMN1; SMN2 (0.63) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL15908068 0.87 TSHR (0.79) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL21823234 0.87 SMN1; SMN2 (0.57) SMN1; SMN2MAPK1TSHRADORA2AALOX15
SCHEMBL10034853 0.87 MAPK1 (0.61) SMN1; SMN2MAPK1TSHRADORA2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119775700-A Optical film 株式会社钟化 2025-04-08 CN claimed
EP-2301924-B1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND ADEKA CORP (JP) 2015-09-02 EP claimed
EP-2573076-B1 Method for producing 2,4,6-tris(hydroxyphenyl)-1,3,5-triazine compound ADEKA CORP (JP) 2014-08-20 EP claimed
US-8716474-B2 Method for producing 2,4,6-tris(hydroxyphenyl)-1,3,5-triazine compound ADEKA CORPORATION (JP) 2014-05-06 US claimed
EP-2573076-A1 Method for producing 2,4,6-tris(hydroxyphenyl)-1,3,5-triazine compound Adeka Corporation (JP) 2013-03-27 EP claimed
US-20110087023-A1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND ADEKA CORPORATION (JP) 2011-04-14 US claimed
EP-2301924-A1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND Adeka Corporation (JP) 2011-03-30 EP claimed
US-20260140407-A1 ELECTROCHROMIC SHEET AND ELECTROCHROMIC DEVICE SUMITOMO BAKELITE CO., LTD. (JP) 2026-05-21 US disclosed
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-04-09 US disclosed
US-12422750-B2 Method of manufacturing cured film, photocurable resin composition, method of manufacturing laminate, and method of manufacturing semiconductor device FUJIFILM CORPORATION (JP) 2025-09-23 US disclosed
EP-4614220-A1 ELECTROCHROMIC SHEET AND ELECTROCHROMIC DEVICE Sumitomo Bakelite Co.Ltd. (JP) 2025-09-10 EP disclosed
EP-4398289-B1 CURED PRODUCT PRODUCTION METHOD, LAMINATE PRODUCTION METHOD, SEMICONDUCTOR DEVICE MANUFACTURING METHOD, AND PROCESSING LIQUID FUJIFILM CORP (JP) 2025-07-02 EP disclosed
CN-116648313-B Resin composition, cured product, laminate, method for producing cured product, and semiconductor device 富士胶片株式会社 2025-05-16 CN disclosed
EP-0658156-A1 HYDROXYPHENYL-S-TRIAZINES Ciba SC Holding AG (CH) 1995-06-21 EP disclosed
US-5410048-A Protecting photographic materials from actinic light CIBA-GEIGY CORPORATION (US) 1995-04-25 US disclosed
EP-0648753-A1 Process for the production of 1,3,5-triazine CIBA-GEIGY AG (CH) 1995-04-19 EP disclosed
US-5354794-A Antipeeling; for automobiles CIBA-GEIGY CORPORATION (US) 1994-10-11 US disclosed
WO-1994018278-A2 ELECTRO COAT/BASE COAT/CLEAR COAT FINISHES STABILIZED WITH s-TRIAZINE UV ABSORBERS CIBA-GEIGY AG (CH) 1994-08-18 WO disclosed
US-5300414-A Tris(2-hydroxyphenyl)-s-triazines CIBA-GEIGY CORPORATION (US) 1994-04-05 US disclosed
WO-1994005645-A1 HYDROXYPHENYL-S-TRIAZINES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY NR2E3, STRA6, UACA SMN1; SMN2 3410/4885MAPK1 3316/4885TSHR 195/4885
US-20260140407-A1 ELECTROCHROMIC SHEET AND ELECTROCHROMIC DEVICE GJB2, LNPK, KCNN2 SMN1; SMN2 1094/4885MAPK1 790/4885TSHR 4703/4885
US-20110087023-A1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND QSOX1, TST, TH SMN1; SMN2 4814/4885MAPK1 2538/4885TSHR 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.